Drug profile · INN
nusinersen
SPINRAZA
nusinersen (SPINRAZA) is an FDA-listed pharmaceutical active ingredient. Associated with Biogen.
EMA: approved TGA: approved Musculo-skeletal system (M09) M09
Patents linked 0
Pipeline programs 4
News articles 1
Drug details — nusinersen
- Class
- Musculo-skeletal system (M09)
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.83
Quick answer
nusinersen (SPINRAZA) is an FDA-listed pharmaceutical active ingredient. Associated with Biogen.
Key facts
INN nusinersen
Brand SPINRAZA
Therapeutic class Musculo-skeletal system (M09)
ATC code M09
Originator Biogen
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nusinersen?
nusinersen (SPINRAZA) is an FDA-listed pharmaceutical active ingredient. Associated with Biogen.
What is the brand name for nusinersen?
SPINRAZA is a marketed brand name for nusinersen. Check FDA Drugs@FDA for the current US label holder and prescribing information.